Evidence map›Paper›PMID 22067702›Full record

ArticleJournal of proteomics2012

The effect of selenium enrichment on baker's yeast proteome.

Karam El-Bayoumy, Arunangshu Das, Stephen Russell, Steven Wolfe, Rick Jordan, Kutralanathan Renganathan, Thomas P Loughran, Richard Somiari

Registry-linked trialAbstract read
In one paragraph

Article in Journal of proteomics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04014283 (Prevention of Females Malignancies in Families With Hereditary Breast Cancer by Personalized Optimization of Se Levels in the Organism.), which is not on this map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04014283 naunknown statusnot on this mapstarted 2014, after this paper: background citation

Prevention of Females Malignancies in Families With Hereditary Breast Cancer by Personalized Optimization of Se Levels in the Organism.

TypeinterventionalSponsorRead-Gene S.A.Ran2014 to 2023Enrolled7,000ConditionsBreast NeoplasmsArmsSelenium supplementation or placebo treatment, Diet modification, Selenium supplementation or placebo treatment and diet modification
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Accumulation and metabolism of selenium by yeast cells.Applied microbiology and biotechnology · 2015
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Karam El-BayoumyDepartment of Biochemistry and Molecular Biology, Penn State College of Medicine, Hershey, PA 17033, USA. kee2@psu.edu
Arunangshu Das
Stephen Russell
Steven Wolfe
Rick Jordan
Kutralanathan Renganathan
Thomas P Loughran
Richard Somiari
Integra LifeSciences (United States) · USPennsylvania State University · USPenn State Milton S. Hershey Medical Center · US

Funding

UNIVERSITY OF PITTSBURGH CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTE: BPCAUL1RR024153 · NCRR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2006 to 2011
$73.9M
University of Pittsburgh Clinical and Translational Science InstituteUL1TR000005 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2012 to 2015
$50.8M
The influence of selenium on biomarkers of prostate cancer riskR01CA127729 · NCI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI EL-BAYOUMY, KARAM E · 2008 to 2012
$2.1M
NCATS NIH HHS UL1 TR000005NCI NIH HHS R01 CA127729NCRR NIH HHS UL1 RR024153
6 · The paper itself

Abstract

The use of regular yeast (RY) and selenium-enriched yeast (SEY) as dietary supplement is of interest because the Nutritional Prevention of Cancer (NPC) trial revealed that SEY but not RY decreased the incidence of prostate cancer (PC). Using two-dimensional difference in gel electrophoresis (2D-DIGE)-tandem mass spectrometry (MS/MS) approach, we performed proteomic analysis of RY and SEY to identify proteins that are differentially expressed as a result of selenium enrichment. 2D-DIGE revealed 96 candidate protein spots that were differentially expressed (p≤0.05) between SEY and RY. The 96 spots were selected, sequenced by LC/MS/MS and 37 proteins were unequivocally identified. The 37 identified proteins were verified with ProteinProphet software and mapped to existing Gene Ontology categories. Furthermore, the expression profile of 5 of the proteins with validated or putative roles in the carcinogenesis process, and for which antibodies against human forms of the proteins are available commercially was verified by western analysis. This study provides evidence for the first time that SEY contains higher levels of Pyruvate Kinase, HSP70, and Elongation factor 2 and lower levels of Eukaryotic Translation Initiation Factor 5A-2 and Triosephosphate Isomerase than those found in RY.

Indexed as

Antibodies, NeoplasmDietary SupplementsGene Expression Regulation, FungalHumansIncidenceMaleProstatic NeoplasmsProteomeProteomicsSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsSeleniumSoftwareAntibodies, NeoplasmProteomeSaccharomyces cerevisiae ProteinsSelenium

Identifiers

PMID22067702
PMCPMC3246083
OpenAlexW2087601097

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.